About this trial
The study will investigate the use of Electroencephalography (EEG) in understanding mild cognitive impairment (MCI). EEG is commonly used in everyday clinical practice for the assessment of a wide range of neurological disorders. It records the brains spontaneous electrical signals and offers a non-invasive means of visually evaluating brain signals. By analysing these signals, we aim to uncover invaluable insights into cognitive impairments and the ageing brains cognitive processes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with mild cognitive impairments (MCI) or mild dementia
Normal or corrected-to-normal vision
Can maintain sitting with or without support for around 60 minutes continuously
Cognitive and language abilities to understand and participate in the study protocol and able to give consent and understand instructions
Disqualifiers
Severe cognitive impairment that would interfere with their ability to comply with the experimental protocol or provide informed consent
Pre-existing severe systemic disorders like active cancer, end-stage pulmonary or cardiovascular disease, psychiatric illness including severe alcohol or drug abuse
Past history of epilepsy- with seizures in last 12 months
History of photosensitive epilepsy.
Trial population
Participants will be from the Sheffield Memory Clinic run by Dr Blackburn. This sees approximately 400 new patients per year of whom 15-20% have MCI, it is a research active clinic, and we have a database of people interested in taking part in research. Suitable participants will be identified in the clinic by a member of their clinical staff or contacted from their database.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
MoCA Test
Diagnostic testMoCA (Montreal Cognitive Assessment or The MoCA Test) was validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in hundreds of peer-reviewed studies since 2000. MoCA has been widely adopted in clinical settings and used in academic and non-academic research around the world. The sensitivity of MoCA for detecting MCI is 90%, compared to 18% for the MMSE. Prospective participants meeting the eligibility criteria, as determined by the Montreal Cognitive Assessment (MoCA) test, will be invited to the Brain- Computer Interface (BCI) laboratory at the Kroto Research Centre on the University of Sheffield north campus to participate in the study.
Random Dot Motion (RDM) task
DeviceRandom Dot Motion task (RDM) has been widely used in research on spatial attention, and decision-making ability, etc., and its results (accuracy and reaction time) can be used as indicators to detect spatial attention. During the assessment, participants were required to monitor a series of dots in constant random motion on the screen. The dots sometimes moved coherently together to the left or right, and participants were required to press the left mouse button when they perceived them moving to the left and the right mouse button when they observed them moving to the right. We are going to use the motion coherence level of 50%. The higher the coherence level, the greater the number of dots moving together, and the combination of the moving direction and coherence level of the dots appear randomly during the task.
P300-BCI task without feedback
DeviceTwo different speller matrix sizes: 3×3 and 5×5, two inter-stimulus intervals (ISIs): 117ms (i.e., commonly used ISI for healthy adults) and 175ms (i.e., 50% longer than the widely used ISI) and two spelling words (QUICK and JUMP) are designed in this experiment to explore the calibration accuracy of these eight parameter combinations in the young and old groups and obtain the best parameter combination. The matrix contains letters and digits, and the target letters will be displayed below the matrix letter by letter. When the speller runs, the rows and columns in the matrix will flash 15 times each randomly. Each flash will last for 55ms, and the subsequent ISI will last for different times according to different parameter designs. Participants only need to focus on the target letter and silently count the number it flashes, as flashing target letters can generate P300 if well attended.
Treatment groups
Trial outcomes
Primary outcomes
Accuracy of the Brain-Computer Interface (BCI) model across different settings which is being tested
This outcome measure will assess the accuracy of the P300-based Brain-Computer Interface (BCI) system across different settings being tested. Using state-of-the-art BCI classification models, the accuracy of P300-BCI system classification will be determined through offline analysis of EEG data collected during the experiment.
Secondary outcomes
The scores of the Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA) was validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in hundreds of peer-reviewed studies since 2000. It has been widely adopted in clinical settings and used in academic and non-academic research around the world. The results of MoCA are interpreted based on a score range, with higher scores indicating less cognitive impairment: 26-30: Normal cognition 18-25: Mild cognitive impairment 10-17: Moderate cognitive impairment Under 10: Severe cognitive impairment
Reaction times of the Random Dot Motion (RDM) test
In the Random Dot Motion (RDM) test, the reaction times of the mild cognitive impairment (MCI) patients are slower and more variable.
Error rates of the Random Dot Motion (RDM) test
In the Random Dot Motion (RDM) test, the error rates of the mild cognitive impairment (MCI) patients are higher, particularly in challenging conditions (e.g., low coherence level).
Characteristics of the P300 amplitude across different settings
P300 amplitude refers to the magnitude of the positive deflection in the EEG signal occurring approximately 300 milliseconds after the presentation of a target stimulus. The P300 amplitude is typically measured in microvolts (µV). Data will be averaged across trials for each participant.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: